J&J hires Neil Patrick Harris to narrate Listerine "documentary"

Share this article:
J&J hires Neil Patrick Harris to narrate Listerine "documentary"
J&J hires Neil Patrick Harris to narrate Listerine "documentary"
Johnson & Johnson's McNeil division recruited actor Neil Patrick Harris (of Doogie Howser and Dr. Horrible fame) to narrate a three-minute online documentary on the history and uses of Listerine.

An outshoot of the brand's “Deepest Clean” TV campaign, it's a genre-bender -- part informational video, part gross-out and part horror movie. In a “Behind the scenes” clip at the campaign's website, thisisyourmouth.com, Harris snarks that after learning all about how overrun with bacteria our mouths are, he'll swish “two, maybe seven times a day.” The film also hints that not using mouthwash could lead to heart disease or diabetes.

“Emerging science suggests that advanced gum disease may be linked to other disorders, such as pneumonia, diabetes and heart disease,” says dentist John E. Dodes, DDS in the film, adding “Some studies have found oral bacteria in the arteries of people with heart disease.” At the end of the video, a disclaimer flashes on the screen, advising: “Emerging science suggests an association between periodontitis (advanced gum disease) and broader health problems, but a cause and effect relationship has not been established. Listerine Antiseptic has been indicated to help prevent or reduce plaque and gingivitis. It is not indicated for periodontitis or other diseases.”

For every viewing of the film, McNeil will donate a dollar to the Children's Oral Health Foundation (“America's Toothfairy”) up to $15,000. Edelman is handling PR for the film.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...